Agglutination · What Is It, Purpose, and More

Agglutination, which refers to the clumping of particles together, is an antigen-antibody reaction that occurs when an antigen, a molecule capable of triggering the adaptive immune response, is mixed with its corresponding antibody at a suitable pH and temperature. This reaction occurs because antibodies have multiple binding sites, allowing them to cross-link antigens on different particles, forming visible aggregates.  

The first step in the agglutination process is the attachment of a specific antibody to the corresponding antigen. IgM antibodies react best at cold temperatures, usually between 4-22º C, or 39-71° F, whereas IgG antibodies react best at warm temperatures, typically around 37º C, or 98.6° F. Their preference for differing temperatures is why IgM antibodies are also called “cold agglutinins” and IgG antibodies “warm agglutinins.” For agglutination to occur, the ratio of antigen to antibody must be similar; otherwise, clumping of particles will not happen. Excessive amounts of antigens or antibodies in the solution may prevent agglutination; a phenomenon called prozone and postzone effect, respectively. 

The purpose of agglutination is to detect the presence of specific antigens or antibodies in samples of bodily fluids, such as blood, saliva, urine, or cerebrospinal fluid (CSF); as well as to identify specific strains of bacteria in microbiological cultures.  

Blood Typing 

One of the most common applications of agglutination in clinical practice is blood typing, where the donor and recipient’s blood is typed and crossmatched to prevent hemolytic transfusion reactions, which often occur in ABO blood group incompatibility. In this situation, the recipient’s preformed antibodies attack the donor red blood cells, resulting in their destruction or hemolysis.  

During blood typing, serum with known anti-A and anti-B antibodies is mixed with an individual’s red blood cells. If an agglutination reaction occurs, it means the red blood cells tested have that specific antigen—the A or B glycoprotein—on their surface. For example, if anti-A serum is mixed with an individual’s red blood cells and an agglutination reaction occurs but doesn’t occur when mixed with anti-B serum, that person has blood type A. Similarly, if an agglutination reaction occurs when mixed with anti-A and anti-B serum, that person has blood type AB. The same process can be done with anti-Rh serum to determine the individual’s Rh status. 

Infectious Disease 

Agglutination tests are also commonly used in the diagnosis of several infectious diseases and to identify specific strains of bacteria that may be causing an infection.  

As an example, latex agglutination tests (LATs) use small latex beads coated with specific antibodies or antigens to detect their corresponding antigen or antibody in a sample. The binding of the target antigen or antibody to the coated beads causes visible clumping, indicating a positive result. LATs can be used to detect Group A streptococcus antigens in throat swabs or to identify toxins like Clostridium difficile in stool samples.  

While agglutination tests can provide rapid results, they may not be able to detect very low antigen or antibody levels and can also give false positives due to cross-reactivity, which is why results are often confirmed with more accurate methods.  

Drug Testing 

Agglutination-inhibition tests, which are used in some rapid drug tests, use the principle of competitive binding to detect small molecules such as drugs or their metabolites that cannot directly cause agglutination due to their size. If the drug is present in the sample, it competes with a drug-coated particle for binding to specific antibodies, which prevents agglutination. Unlike with other methods, a positive result is when no agglutination occurs, indicating the presence of the drug in the sample.